Buscar
Mostrando ítems 31-40 de 819
Perfil molecular dos carcinomas ductais in situ de alto grau da mama puros ou associados a carcinoma invasor. Detecção por imunofenotipagem molecular.
(Universidade Federal de Minas GeraisUFMG, 2010-12-16)
Introduction: Recent studies using cDNA microarrays identified distinct groups of tumours, with different prognosis, and developed a new classification of breast carcinomas based on molecular profile. Many studies evaluated ...
Cytological result of in situ ductal carcinoma in nipple discharge: a rare diagnosis
(2014)
Background: More than half of women present nipple discharge during reproductive age. Case: This case is about a 36 years old woman with unilateral spontaneous hyaline nipple discharge associated with breast pain. The study ...
DUCTAL CARCINOMA IN-SITU OF THE BREAST - HISTOLOGIC CATEGORIZATION AND ITS RELATIONSHIP TO PLOIDY AND IMMUNOHISTOCHEMICAL EXPRESSION OF HORMONE RECEPTORS, P53, AND C-ERBB-2 PROTEIN
(Wiley-Blackwell, 1995-04-15)
Background. Ductal carcinoma in situ (DCIS) of the breast has been diagnosed increasingly since the advent of mammography. However, the natural history of these lesions remains uncertain. Ductal carcinoma in situ of the ...
DUCTAL CARCINOMA IN-SITU OF THE BREAST - HISTOLOGIC CATEGORIZATION AND ITS RELATIONSHIP TO PLOIDY AND IMMUNOHISTOCHEMICAL EXPRESSION OF HORMONE RECEPTORS, P53, AND C-ERBB-2 PROTEIN
(Wiley-Blackwell, 1995-04-15)
Background. Ductal carcinoma in situ (DCIS) of the breast has been diagnosed increasingly since the advent of mammography. However, the natural history of these lesions remains uncertain. Ductal carcinoma in situ of the ...
Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c‐erbB‐2 protein
(1995-01-01)
Background. Ductal carcinoma in situ (DCIS) of the breast has been diagnosed increasingly since the advent of mammography. However, the natural history of these lesions remains uncertain. Ductal carcinoma in situ of the ...
HER2 como factor predictivo de respuesta a la quimioterapia neoadyuvante en los tumores primarios (T) por carcinoma ductal de mama
(Universidad Privada Antenor OrregoPE, 2024)
El presente proyecto de tesis tiene como objetivo principal demostrar el
factor predictivo del status HER2 para la respuesta a la quimioterapia neo
adyuvante en tumores primarios (T) por carcinoma ductal de mama en
pacientes ...
Immunohistochemical detection of polyductin and co-localization with liver progenitor cell markers during normal and abnormal development of the intrahepatic biliary system and in adult hepatobiliary carcinomas
(WILEY-BLACKWELL, 2009)
The longest open reading frame of PKHD1 (polycystic kidney and hepatic disease 1), the autosomal recessive polycystic kidney disease (ARPKD) gene, encodes a single-pass, integral membrane protein named polyductin or ...
Extra-tumoral breast tissue in breast cancer patients: Variations with steroid contraceptive use
(2006)
The association between oral contraceptive (OC) use and benign breast changes in extra-tumoral breast tissue was studied histologically in 1,503 breast cancer patients from The WHO Collaborative Study of Neoplasia and ...
Carcinoma ductal invasivo mamário esporádico: uma abordagem histoquímica e imunohistiquímica
(Universidade Federal de Pernambuco, 2014)
Expresión de receptores hormonales frente a indicadores pronósticos en carcinoma de mama.
(2014-01-16)
Cada vez es más importante encontrar factores pronósticos para el carcinoma de mama
que orienten a un tratamiento con mejores resultados. La expresión de receptores
hormonales en el tejido tumoral junto con otras variables ...